Elizabeth R Sharlow

Years Active: 2019-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth R Sharlow, Danielle C Llaneza, Bhanu P Tewari, Garnett A Mingledorff, Anna J Mendelson, Harald Sontheimer, George S Bloom, John S Lazo
Pharmacological profiling identifies divergent chemosensitivities of differentiating and maturing iPSC-derived human cortical neuron populations. The FEBS journal (2023)
Diana Caridha, Richard J Sciotti, Jason Sousa, Brian Vesely, Tesfaye Teshome, Gustave Bonkoungou, Chau Vuong, Susan Leed, Mozna Khraiwesh, Erica Penn, Mara Kreishman-Deitrick, Patricia Lee, Brandon Pybus, John S Lazo, Elizabeth R Sharlow
Combination of Subtherapeutic Doses of Tretazicar and Liposomal Amphotericin B Suppresses and Cures Leishmania major-Induced Cutaneous Lesions in Murine Models. ACS infectious diseases 7 (2) (2021)
John S Lazo, Isabella K Blanco, Nikhil R Tasker, Ettore J Rastelli, James C Burnett, Sharon R Garrott, Duncan J Hart, Rebecca L McCloud, Ku-Lung Hsu, Peter Wipf, Elizabeth R Sharlow
Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase. The Journal of pharmacology and experimental therapeutics 371 (3) (2019)

Elizabeth R Sharlow.css-eqlu8i{font-size:small;padding-left:4px;}